Mark Donohue | Vice President of Investor Relations |
Chirag Patel | Co-Chief Executive Officer and President |
Chintu Patel | Co-Chief Executive Officer |
Todd Branning | Chief Financial Officer |
Andy Boyer | Executive Vice President of Commercial Operations |
Joe Todisco | Senior Vice President of Specialty Commercial |
Pradeep Bhadauria | Chief Scientific Officer |
David Buchen | Chief Legal Officer and Corporate Secretary |
Daniel Busby | RBC Capital Markets |
David Amsellem | Piper Jaffray |
Gary Nachman | BMO Capital Markets |
Greg Gilbert | SunTrust |
Elliot Wilbur | Raymond James |
Chris Schott | JPMorgan |
Ami Fadia | SVB Leerink |
Dana Flanders | Guggenhime Securities |
Good day, and welcome to the Amneal Pharmaceuticals’ Third Quarter 2019 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Mark Donohue, Vice President, Investor Relations and Corporate Communications.